Scarica l'app Stockscreener
91.98
1.04%
-0.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$92.95
Aprire:
$93.75
Volume 24 ore:
961.10K
Relative Volume:
1.40
Capitalizzazione di mercato:
$5.58B
Reddito:
$1.33B
Utile/perdita netta:
$120.04M
Rapporto P/E:
44.87
EPS:
2.05
Flusso di cassa netto:
$172.71M
1 W Prestazione:
-1.06%
1M Prestazione:
-6.91%
6M Prestazione:
-6.35%
1 anno Prestazione:
+12.85%
Intervallo 1D:
$91.80
$93.76
Intervallo di 1 settimana:
$91.80
$94.42
Portata 52W:
$80.98
$111.45
Merit Medical Systems Inc Stock (MMSI) Company Profile
Nome
Merit Medical Systems Inc
Settore
Industria
Telefono
(801) 253-1600
Indirizzo
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Confronta MMSI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MMSI
Merit Medical Systems Inc
|
91.98 | 5.58B | 1.33B | 120.04M | 172.71M | 2.05 |
|
ISRG
Intuitive Surgical Inc
|
509.36 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
168.42 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.40 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
253.68 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
215.82 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-28 | Iniziato | JP Morgan | Overweight |
| 2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-06-28 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-11 | Iniziato | CL King | Buy |
| 2024-02-07 | Iniziato | BofA Securities | Neutral |
| 2023-12-21 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-12-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2021-01-05 | Aggiornamento | Needham | Hold → Buy |
| 2020-09-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-02-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-02-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-12-12 | Downgrade | Wells Fargo | Market Perform → Underperform |
| 2019-09-24 | Iniziato | Oppenheimer | Outperform |
| 2019-09-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Needham | Buy → Hold |
| 2019-07-26 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2018-10-02 | Reiterato | Needham | Buy |
| 2018-08-07 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-07-24 | Reiterato | Needham | Buy |
| 2018-06-01 | Reiterato | Needham | Buy |
| 2018-05-18 | Reiterato | SunTrust | Buy |
| 2018-04-26 | Reiterato | Needham | Buy |
| 2018-04-20 | Iniziato | Needham | Buy |
| 2018-03-01 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2017-08-28 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-07-20 | Iniziato | BofA/Merrill | Buy |
| 2017-06-20 | Iniziato | SunTrust | Buy |
| 2017-04-05 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Merit Medical Systems Inc Borsa (MMSI) Ultime notizie
Alcon and Merit Medical: Creating Regulatory and Quality Business Value with AI - Veeva
Vascular Access Devices Market to Hit US$9.05 Billion by 2030 with 7.1% CAGR | MarketsandMarkets™ - Barchart.com
Where are the Opportunities in (MMSI) - news.stocktradersdaily.com
Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - simplywall.st
Interventional Oncology Devices Market: Advanced Cancer - openPR.com
Merit Medical Systems CEO Fred Lampropoulos sells $38,244 in stock By Investing.com - Investing.com Nigeria
Merit Medical Systems CEO Fred Lampropoulos sells $38,244 in stock - Investing.com Australia
Merit Medical Systems (MMSI) Generated Positive Results from Margin Improvement Initiatives - Insider Monkey
Merit Medical Takes Over Biolife to Expand Post-Procedure Bleeding Control Portfolio - The Healthcare Technology Report.
Uterine Fibroid Treatment Devices Market Set to Witness - openPR.com
Insider Sell: Michael Mcdonnell Sells Shares of Merit Medical Sy - GuruFocus
President and CEO At Merit Medical Systems Sells $951K Of Stock - Nasdaq
Merit Medical Systems CEO Fred Lampropoulos sells $951,200 in stock By Investing.com - Investing.com Canada
Insider Sell: Michael Mcdonnell Sells Shares of Merit Medical Systems Inc (MMSI) - GuruFocus
Merit Medical Systems CEO sells $951,200 in stock By Investing.com - Investing.com South Africa
Merit Medical Systems CEO Fred Lampropoulos sells $951,200 in stock - Investing.com
Merit Medical Systems CEO sells $951,200 in stock - Investing.com
(MMSI) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Do Merit Medical Systems' (NASDAQ:MMSI) Earnings Warrant Your Attention? - Yahoo Finance
Have Merit Medical Systems Insiders Been Selling Stock? - simplywall.st
Merit Medical (MMSI) CEO Sells Significant Shareholding | MMSI S - GuruFocus
Merit Medical CEO sells $1.93M shares of shares - TipRanks
Merit Medical Systems CEO Fred Lampropoulos sells $1.93 million in stock - Investing.com
Merit Medical Systems CEO Fred Lampropoulos sells $1.93 million in stock By Investing.com - Investing.com South Africa
Q1 Earnings Highs And Lows: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Here's How Much $1000 Invested In Merit Medical Systems 20 Years Ago Would Be Worth Today - Benzinga
Prostatic Artery Embolization Market Set to Witness Rising AdoptionMerit Medical, Boston Scientific - openPR.com
When the Price of (MMSI) Talks, People Listen - news.stocktradersdaily.com
Merit Medical Systems (MMSI) Target Price Raised to $110 by Pipe - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent De - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent Developments | MMSI Stock News - GuruFocus
Canaccord Genuity Group Reiterates $112.00 Price Target for Merit Medical Systems (NASDAQ:MMSI) - Defense World
Merit Medical Systems acquires Biolife Delaware in $120 million deal - MSN
Merit Medical Systems: A Quality Business Judged On Its Merits (NASDAQ:MMSI) - Seeking Alpha
Canaccord raises Merit Medical price target to $112 By Investing.com - Investing.com South Africa
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio - sharewise
Canaccord raises Merit Medical price target to $112 - Investing.com Australia
MMSI: Target Price Raised by Canaccord Genuity with Buy Rating M - GuruFocus
Manatee medical manufacturer acquired for $120 million - Business Observer
Merit buys hemostatic device maker Biolife for $120M - MedTech Dive
Merit Medical Systems (MMSI) Target Price Increased by Wells Fargo | MMSI Stock News - GuruFocus
Merit Medical acquires Biolife Delaware - Medical Buyer
Risks To Shareholder Returns Are Elevated At These Prices For Merit Medical Systems, Inc. (NASDAQ:MMSI) - simplywall.st
Merit Medical (MMSI) Price Target Raised by Canaccord Analyst | - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Following Acquis - GuruFocus
Interventional Neuroradiology Market Growth, Trends & - openPR.com
Merit Medical acquires fellow interventional radiology vendor Biolife for $120M - Radiology Business
Merit Medical Systems Inc Azioni (MMSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Merit Medical Systems Inc Azioni (MMSI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Parra Raul Jr. | CFO AND TREASURER |
Jun 13 '25 |
Sale |
93.75 |
15,181 |
1,423,219 |
24,201 |
1.29%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):